Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy
Citations Over TimeTop 10% of 2014 papers
Abstract
Stem/progenitor cell-based therapeutic approach in clinical practice has been an elusive dream in medical sciences, and improvement of stem cell homing is one of major challenges in cell therapy programs. Stem/progenitor cells have a homing response to injured tissues/organs, mediated by interactions of chemokine receptors expressed on the cells and chemokines secreted by the injured tissue. For improvement of directed homing of the cells, many techniques have been developed either to engineer stem/progenitor cells with higher amount of chemokine receptors (stem cell-based strategies) or to modulate the target tissues to release higher level of the corresponding chemokines (target tissue-based strategies). This review discusses both of these strategies involved in the improvement of stem cell homing focusing on mesenchymal stem cells as most frequent studied model in cellular therapies.
Related Papers
- → Vascular repair by endothelial progenitor cells(2008)462 cited
- → Flow Cytometry Detection of Chemokine Receptors for the Identification of Murine Monocyte and Neutrophil Subsets(2015)1 cited
- → Selective transendothelial migration of hematopoietic progenitor cells : a role in homing of progenitor cells(1999)
- Biological Characteristics of Endothelial Progenitor Cells and Its Advancement(2012)
- → Hypoxia-based Stem/Progenitor Cell Therapy: Focus on CXCR4/SDF-1 Axis(2017)